AI-extracted claim
“In 2025, formula company ByHeart shut down its Pennsylvania plant after its products were linked to an infant botulism outbreak and inspectors found safety violations.”
Analyzed on 2026-09-19T09:44:36+00:00 · Last updated 2026-09-19
Plain language: Insufficient evidence was found to render a verdict.
Credibility score
out of 100
Based on 1 source
Low confidence
Original context
Show passage from source article
In 2025, the formula company ByHeart, whose products were linked to an infant botulism outbreak, shut down its Pennsylvania plant after inspectors found safety violations, including mold in a clean-water tank and dead insects in a production area.
Extracted from: Abbott to Pay $385 Million to Settle Infant Formula Allegations , The New York Times
Evidence
This analysis is based on a single source. Confidence is low.
Bias distribution of supporting sources
Mean bias -0.20
Community Takes
No Takes have been written on this claim yet. Sign in to write a Take.